Sep 272011

With the Companys patented Nitric Oxide gas generating and delivery system and its proprietary and patented Nitric Oxide micro tablet medium manufacturing technology the Company has the potential to make a significant and life changing difference in the clinical use of Nitric Oxide in standardized and accepted clinical treatment practices across the world, initially in the treatment of mutating drug-resistant tuberculosis and Swine Flu (H1N1), Influenza A, and other non-clinical uses. Nitric Oxide – Tuberculosis

Sorry, the comment form is closed at this time.